# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Allen Lutz maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $8...
Truist Securities analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from ...
JP Morgan analyst Lisa C. Gill maintained Neutral rating on TDOC with $9 price target, down from $11. Teladoc reports Q1 revenu...
Wells Fargo analyst Stan Berenshteyn maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and lowers the price target fr...
Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $14...
Goldman Sachs analyst David Roman maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $13 to $10.
Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and lowers the price target from $9 to $8.
Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price targe...